Suppr超能文献

镰状细胞病患者在使用肾素-血管紧张素系统阻滞剂前后肾小球高滤过的血流动力学和生物学相关性

Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin-angiotensin system blocker.

机构信息

Service d'Explorations Fonctionnelles Multidisciplinaires, AP-HP, Hôpital Tenon, Sorbonne Université, 75020, Paris, France.

INSERM, UMR_S 1155, AP-HP, Hôpital Tenon, Sorbonne Université, 75020, Paris, France.

出版信息

Sci Rep. 2021 Jun 3;11(1):11682. doi: 10.1038/s41598-021-91161-y.

Abstract

Glomerular hyperfiltration alone or associated with albuminuria is a well-known feature of sickle cell associated nephropathy. Though, glomerular hyperfiltration is currently considered to be related to a high renal plasma flow and chronic hemolysis, cardiac output influence on measured glomerular filtration rate (mGFR) have not been investigated so far. Thirty seven homozygous sickle cell patients (SCA) from the RAND study investigated before and under angiotensin converting enzyme inhibitor (ACEI) were included. Both mGFR and cardiac index (CI) were high (> 110 ml/min/1.73 m and > 3.5 l/m in 81% and 97% of cases) with low systemic vascular resistance (SVR) (< 700 dynes/s/cm) in 38% of cases. mGFR association with CI and SVR were significant at baseline (respectively ρ: 0.44, p = 0.008 and ρ: - 0.37, p = 0.02) and under ACEI (p = 0.007 and 0.01 respectively), in accordance with previous data showing that hyperfiltration was linked to an increased glomerular perfusion and a glomerulomegaly rather than increased capillary hydrostatic pressure. Of notice, after adjustment on CI, mGFR remained associated with reticulocyte count and albuminuria under ACEI (p = 0.006 and 0.02 respectively). Our results suggest that hyperfiltration is tightly linked to an increased cardiac output which may account for an increased renal blood flow. Chronic hemolysis could be a relevant factor accounting for hyperfiltration potentially acting on glomerular enlargement which appears as a key factor. Our data suggest that cardiac output assessment is a relevant tool in the routine management and monitoring of SCA nephropathy.

摘要

肾小球高滤过症单独存在或与白蛋白尿相关是镰状细胞相关肾病的一个众所周知的特征。尽管目前认为肾小球高滤过症与高肾血浆流量和慢性溶血有关,但心脏输出量对测量肾小球滤过率(mGFR)的影响尚未得到研究。本研究纳入了 RAND 研究中 37 名接受过血管紧张素转换酶抑制剂(ACEI)治疗的纯合子镰状细胞病(SCA)患者。mGFR 和心输出量指数(CI)均较高(分别有 81%和 97%的病例>110 ml/min/1.73 m 和>3.5 l/m),而全身血管阻力(SVR)较低(<700 达因/秒/cm )在 38%的病例中。在基线时(分别为 ρ:0.44,p=0.008 和 ρ:-0.37,p=0.02)和 ACEI 治疗下(分别为 p=0.007 和 0.01),mGFR 与 CI 和 SVR 显著相关,这与先前的数据一致,表明高滤过症与肾小球灌注增加和肾小球肥大有关,而与毛细血管静水压力增加无关。值得注意的是,在调整 CI 后,mGFR 在 ACEI 治疗下仍与网织红细胞计数和白蛋白尿相关(分别为 p=0.006 和 0.02)。我们的结果表明,高滤过症与心输出量增加密切相关,这可能导致肾血流量增加。慢性溶血可能是导致高滤过症的一个相关因素,可能作用于肾小球增大,这是一个关键因素。我们的数据表明,心输出量评估是镰状细胞肾病常规管理和监测的一个相关工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69a/8175337/507098f93a38/41598_2021_91161_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验